Latest Market News

Prescient Therapeutics has achieved a key regulatory milestone with the European Medicines Agency granting Orphan Drug Designation for its PTX-100 therapy targeting Cutaneous T-cell Lymphomas, enhancing its commercial and clinical prospects in Europe.

Red Mountain Mining Ltd has made a strong entrance on the US OTCQB market, surging 36% on its first day of trading as it advances key antimony and gold projects across the US and Australia.

Vulcan Energy reports robust drilling results and lithium grade confirmation from its Phase One Lionheart Project wells in Germany, reinforcing confidence in its sustainable lithium production plans.

Helloworld Travel has tabled a non-binding offer to acquire all remaining shares of Webjet Group at a 31% premium, aiming to create a stronger travel booking powerhouse.

Ridley Corporation reports solid FY25 earnings growth and outlines a diversified growth strategy for FY26, anchored by its recent Incitec Pivot Fertilisers acquisition.

TPG Telecom has successfully raised $300 million through its institutional reinvestment plan, issuing new shares at a discount to offset recent capital returns and strengthen its balance sheet. The plan faced adjustments due to a tragic incident and volatile market conditions.

Tivan Limited has made significant progress on its Speewah Fluorite Project in Western Australia, completing a major drilling phase and advancing its Feasibility Study, now scheduled for completion in February 2026. The project aims to produce acidgrade fluorspar for global markets, supported by strong joint venture partnerships and strategic financing.

SEEK Limited’s CEO presented the company’s financial guidance for FY2026 during the 2025 Annual General Meeting, signaling strategic priorities ahead.

SportsHero has officially launched its HeroPlay mobile gaming platform in Indonesia through a partnership with Indosat Ooredoo Hutchison, offering over 600 instantly playable HTML5 games to nearly 99 million potential users.

Acusensus Limited has raised its FY26 revenue guidance to $83-$87 million, driven by significant new contracts in the US and New Zealand and expansions in Australia. This upgrade signals strong momentum in the company’s AI-powered road safety enforcement business.

BCAL Diagnostics is preparing to launch its Avantect® pancreatic and ovarian cancer blood tests in Australia by January 2026, following key regulatory approvals and promising clinical data. The company also broadens the reach of its BREASTESTplus™ breast cancer test, targeting a larger segment of women with dense breast tissue.

Decidr AI Industries has announced a strategic acquisition of Delaware-based Sugarwork Inc., marking its official entry into the US market and enhancing its Agentic AI platform with advanced knowledge transfer capabilities.